The reactive T cells then exit the skin, re-enter the lymphatic or vascular spaces, and recirculate or undergo the process of natural cell death. In CTCL, specific skin-homing T lymphocytes ...

Accurately diagnosing T-cell lymphoma often takes time. Given that cutaneous T-cell lymphoma shares symptoms with many other benign conditions, it takes an average of 6 years from disease onset to ...

extranodal T-cell lymphoma, cutaneous T-cell lymphomas (Sézary syndrome and Mycosis fungoides), anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma.

The company’s key focus is on HyBryte™, a novel photodynamic therapy for cutaneous T-cell lymphoma, and the expansion of synthetic hypericin into psoriasis and other inflammatory diseases.